NIH Redraws Dollar-Doler Divisions

Anne MacNamara For years, when neuroscientists who study taste and smell submitted research grant proposals to the National Institutes of Health, half of the reviewers were not experts in the subspecialty. Instead, they studied language. Likewise, when language neuroscientists submitted proposals, their fates lay partly in the hands of people whose main interest in the human head started at the mouth and nose and ended in parts of the brain unrelated to language. "Historically, we had been pl

Written byJohn Dudley Miller
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

For years, when neuroscientists who study taste and smell submitted research grant proposals to the National Institutes of Health, half of the reviewers were not experts in the subspecialty. Instead, they studied language. Likewise, when language neuroscientists submitted proposals, their fates lay partly in the hands of people whose main interest in the human head started at the mouth and nose and ended in parts of the brain unrelated to language.

"Historically, we had been placed with them because the National Institute [on] Deafness and Communication [Disorders] dealt with both language and chemical senses," says chemoreceptor scientist Charles Greer, professor of neurosurgery and neurobiology at Yale University School of Medicine. "We were quite distant from them ...."

Such boundaries are finally changing because of an aggressive NIH reorganization plan launched in 1997. The first redesigned sections, in the hematology integrated review groups (IRGs), met in June. All new IRGs are ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies